Overview of the IL-1 Family in Innate Inflammation and Acquired Immunity

Overview

Journal Immunol Rev

Specialties Allergy & Immunology
General Surgery

Date 2017 Dec 17

PMID 29247995

Citations 809

Authors

Charles A Dinarello

Affiliations

Soon will be listed here.

Abstract

The interleukin-1 (IL-1) family of cytokines and receptors is unique in immunology because the IL-1 family and Toll-like receptor (TLR) families share similar functions. More than any other cytokine family, the IL-1 family is primarily associated with innate immunity. More than 95% of living organisms use innate immune mechanisms for survival whereas less than 5% depend on T- and B-cell functions. Innate immunity is manifested by inflammation, which can function as a mechanism of host defense but when uncontrolled is detrimental to survival. Each member of the IL-1 receptor and TLR family contains the cytoplasmic Toll-IL-1-Receptor (TIR) domain. The 50 amino acid TIR domains are highly homologous with the Toll protein in Drosophila. The TIR domain is nearly the same and present in each TLR and each IL-1 receptor family. Whereas IL-1 family cytokine members trigger innate inflammation via IL-1 family of receptors, TLRs trigger inflammation via bacteria, microbial products, viruses, nucleic acids, and damage-associated molecular patterns (DAMPs). In fact, IL-1 family member IL-1a and IL-33 also function as DAMPs. Although the inflammatory properties of the IL-1 family dominate in innate immunity, IL-1 family member can play a role in acquired immunity. This overview is a condensed update of the IL-1 family of cytokines and receptors.

Citing Articles

Pharmacokinetics and Pharmacodynamics of KT-474, a Novel Selective Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) Degrader, in Healthy Adults.

Agarwal S, McDonald A, Campbell V, Chen D, Davis J, Rong H Clin Transl Sci. 2025; 18(3):e70181.

PMID: 40055981 PMC: 11889407. DOI: 10.1111/cts.70181.

The potential impact of RNA splicing abnormalities on immune regulation in endometrial cancer.

Cao M, Yan J, Ding Y, Zhang Y, Sun Y, Jiang G Cell Death Dis. 2025; 16(1):148.

PMID: 40032844 PMC: 11876696. DOI: 10.1038/s41419-025-07458-7.

IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling.

M Bader S, Scherer L, Schaefer J, Cooney J, Mackiewicz L, Dayton M Cell Death Differ. 2025; .

PMID: 40016339 DOI: 10.1038/s41418-025-01459-x.

Hexavalent chromium (Cr) induces oxidative stress, inflammatory response, apoptosis, and DNA damage in the liver of largemouth bass by inhibiting the Nrf2-Keap1 signal pathway.

Zhou X, Yang X, Liu X, Jiang L, Jiang Y Fish Physiol Biochem. 2025; 51(2):53.

PMID: 39992480 DOI: 10.1007/s10695-025-01469-z.

Comprehensive view of suicide: A neuro-immune-endocrine approach.

Ponce-Regalado M, Becerril-Villanueva E, Maldonado-Garcia J, Moreno-Lafont M, Martinez-Ramirez G, Jacinto-Gutierrez S World J Psychiatry. 2025; 15(2):98484.

PMID: 39974471 PMC: 11758041. DOI: 10.5498/wjp.v15.i2.98484.

References

Smithrithee R, Niyonsaba F, Kiatsurayanon C, Ushio H, Ikeda S, Okumura K . Human β-defensin-3 increases the expression of interleukin-37 through CCR6 in human keratinocytes. J Dermatol Sci. 2014; 77(1):46-53. DOI: 10.1016/j.jdermsci.2014.12.001. View

Imaeda H, Takahashi K, Fujimoto T, Kasumi E, Ban H, Bamba S . Epithelial expression of interleukin-37b in inflammatory bowel disease. Clin Exp Immunol. 2013; 172(3):410-6. PMC: 3646440. DOI: 10.1111/cei.12061. View

Coeshott C, Ohnemus C, Pilyavskaya A, Ross S, Wieczorek M, Kroona H . Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci U S A. 1999; 96(11):6261-6. PMC: 26869. DOI: 10.1073/pnas.96.11.6261. View

Maeno N, Takei S, Imanaka H, Yamamoto K, Kuriwaki K, Kawano Y . Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome. Arthritis Rheum. 2004; 50(6):1935-8. DOI: 10.1002/art.20268. View

Boutet M, Bart G, Penhoat M, Amiaud J, Brulin B, Charrier C . Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease. Clin Exp Immunol. 2015; 184(2):159-73. PMC: 4837235. DOI: 10.1111/cei.12761. View

Onoufriadis A, Simpson M, Pink A, Di Meglio P, Smith C, Pullabhatla V . Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet. 2011; 89(3):432-7. PMC: 3169817. DOI: 10.1016/j.ajhg.2011.07.022. View

Banda N, Vondracek A, Kraus D, Dinarello C, Kim S, Bendele A . Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein. J Immunol. 2003; 170(4):2100-5. DOI: 10.4049/jimmunol.170.4.2100. View

Dinarello C, Nold-Petry C, Nold M, Fujita M, Li S, Kim S . Suppression of innate inflammation and immunity by interleukin-37. Eur J Immunol. 2016; 46(5):1067-81. PMC: 5003108. DOI: 10.1002/eji.201545828. View

Siegmund B, Fantuzzi G, Rieder F, Gamboni-Robertson F, Lehr H, Hartmann G . Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am J Physiol Regul Integr Comp Physiol. 2001; 281(4):R1264-73. DOI: 10.1152/ajpregu.2001.281.4.R1264. View

10.

Coll-Miro M, Francos-Quijorna I, Santos-Nogueira E, Torres-Espin A, Bufler P, Dinarello C . Beneficial effects of IL-37 after spinal cord injury in mice. Proc Natl Acad Sci U S A. 2016; 113(5):1411-6. PMC: 4747716. DOI: 10.1073/pnas.1523212113. View

11.

Lee J, Kim S, Lewis E, Azam T, Reznikov L, Dinarello C . Differences in signaling pathways by IL-1beta and IL-18. Proc Natl Acad Sci U S A. 2004; 101(23):8815-20. PMC: 423278. DOI: 10.1073/pnas.0402800101. View

12.

Gerard S, Le Goff B, Maugars Y, Berthelot J, Malard O . Lasting remission of a Muckle-Wells syndrome with CIAS-1 mutation using half-dose anakinra. Joint Bone Spine. 2007; 74(6):659. DOI: 10.1016/j.jbspin.2007.01.032. View

13.

Fantuzzi G, Mendoza L, Fuentes A, Anasagasti M, Martin J, Carrascal T . IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc Natl Acad Sci U S A. 2000; 97(2):734-9. PMC: 15399. DOI: 10.1073/pnas.97.2.734. View

14.

Di Paolo N, Shayakhmetov D . Interleukin 1α and the inflammatory process. Nat Immunol. 2016; 17(8):906-13. PMC: 5152572. DOI: 10.1038/ni.3503. View

15.

Liang Y, Jie Z, Hou L, Yi P, Wang W, Kwota Z . IL-33 promotes innate IFN-γ production and modulates dendritic cell response in LCMV-induced hepatitis in mice. Eur J Immunol. 2015; 45(11):3052-63. PMC: 4813322. DOI: 10.1002/eji.201545696. View

16.

Vaidya V, Waikar S, Ferguson M, Collings F, Sunderland K, Gioules C . Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci. 2009; 1(3):200-8. PMC: 2638059. DOI: 10.1111/j.1752-8062.2008.00053.x. View

17.

Sedhom M, Pichery M, Murdoch J, Foligne B, Ortega N, Normand S . Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice. Gut. 2012; 62(12):1714-23. PMC: 3841767. DOI: 10.1136/gutjnl-2011-301785. View

18.

Lingel A, Weiss T, Niebuhr M, Pan B, Appleton B, Wiesmann C . Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes. Structure. 2009; 17(10):1398-410. PMC: 2766095. DOI: 10.1016/j.str.2009.08.009. View

19.

Xia L, Shen H, Lu J . Elevated serum and synovial fluid levels of interleukin-37 in patients with rheumatoid arthritis: Attenuated the production of inflammatory cytokines. Cytokine. 2015; 76(2):553-557. DOI: 10.1016/j.cyto.2015.06.005. View

20.

Weber A, Wasiliew P, Kracht M . Interleukin-1 (IL-1) pathway. Sci Signal. 2010; 3(105):cm1. DOI: 10.1126/scisignal.3105cm1. View